<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28057" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Physiology, Pulmonary Vascular Resistance</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Widrich</surname>
            <given-names>Jason</given-names>
          </name>
          <aff>University of Florida</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shetty</surname>
            <given-names>Mrin</given-names>
          </name>
          <aff>University of Chicago (NorthShore)</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jason Widrich declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mrin Shetty declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>31</day>
          <month>1</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28057.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Pulmonary vascular resistance (PVR) is the resistance against blood flow from the 4 pulmonary&#x000a0;veins of the lung to the left atrium. It is most commonly modeled using a modification of Ohm&#x02019;s law (see <bold>Image.&#x000a0;</bold>Pulmonary Vascular Resistance Derived from Ohm's Law). Input pressure represents the mean pulmonary arterial pressure (15 mm Hg). The output pressure represents the pulmonary venous pressure, equivalent to the pulmonary capillary wedge or left atrial pressure (5 to 6 mm Hg). Total blood flow represents the cardiac output (5 to 6 L/min). A normal value for pulmonary vascular resistance using conventional units is 0.25 to 1.6 mmHg&#x000b7;min/l. Pulmonary vascular resistance&#x000a0;is also represented in units of dynes/sec/cm<sup>-5</sup>&#x000a0;(normal = 37dynes/sec/cm<sup>-5</sup> to 250 dynes/sec/cm<sup>-5</sup>).<xref ref-type="bibr" rid="article-28057.r1">[1]</xref></p>
        <p>Poiseuille&#x02019;s law has been used to model PVR (see <bold>Image.&#x000a0;</bold>Poiseuille's Law Modeling Pulmonary Vascular Resistance). In this equation, <italic toggle="yes">l</italic> represents the length of the tube or vessel, <italic toggle="yes">r</italic> its radius, and <italic toggle="yes">n</italic> the fluid's viscosity. Poiseuille&#x02019;s law clarifies the impact of the radius on resistance. For example, a 50% reduction in radius increases the resistance 16-fold. However, Ohm&#x02019;s and Poiseuille&#x02019;s laws are approximations of PVR. Both equations assume that blood flow is constant and linear, but it is pulsatile and laminar. Pulmonary blood vessels&#x000a0;are dynamic, multi-layered tissues that&#x000a0;expand to accommodate increased flow. Additionally, the non-homogenous quality&#x000a0;of blood makes it difficult to ascertain a single value for viscosity. Blood viscosity varies with shear rate.<xref ref-type="bibr" rid="article-28057.r2">[2]</xref><xref ref-type="bibr" rid="article-28057.r3">[3]</xref></p>
        <p>The pressure drop from the pulmonary&#x000a0;veins to the left atrium is approximately 10 mm Hg compared to a 100 mm Hg pressure gradient in the systemic circulation. Therefore, PVR is one-tenth of the resistance of systemic circulation. Low PVR maximizes the distribution of blood to the peripheral alveoli and&#x000a0;facilitates&#x000a0;gas exchange. Low resistance also&#x000a0;enables the pulmonary system to pump the total cardiac output at low pressures.</p>
        <p>Most of the total vascular resistance and distribution of blood flow in the pulmonary circuit&#x000a0;is due to the cross-sectional area of&#x000a0;capillaries rather than veins, venules, or arteries. However, pulmonary resistance&#x000a0;is approximately equally divided between arteries, capillaries, and veins. Because resistance increases in the capillaries, the largest drop in pulmonary pressure occurs, and to a lesser extent, in the small pulmonary arteries.&#x000a0;In the systemic circulation, the largest pressure drop occurs in the arterioles.<xref ref-type="bibr" rid="article-28057.r1">[1]</xref></p>
      </sec>
      <sec id="article-28057.s2" sec-type="Mechanism">
        <title>Mechanism</title>
        <p>Multiple mechanisms regulate and contribute to pulmonary vascular resistance.&#x000a0;Broad categories include pulmonary vascular pressure, lung volume, gravity, smooth muscle tonicity, and alveolar hypoxia.<xref ref-type="bibr" rid="article-28057.r4">[4]</xref></p>
        <p>
<bold>Pulmonary Intravascular Pressure</bold>
</p>
        <p>As cardiac input increases, for example, during exercise, the pulmonic circulation must adapt to accommodate this increased forward flow. Therefore, pulmonary intravascular pressure and pulmonary vascular resistance are inversely related. Experiments have shown that increasing the pulmonary arterial pressure while holding the left atrial pressure constant decreases pulmonary vascular resistance.</p>
        <p>This decrease occurs via&#x000a0;2 mechanisms: capillary recruitment and capillary distension.</p>
        <p>The first mechanism is capillary recruitment. Some pulmonary capillaries are partially or entirely closed at baseline, impeding blood flow. Capillary recruitment refers to opening closed capillaries during states of increased blood flow.&#x000a0;Flow distribution over a greater cross-sectional surface area reduces the overall vascular resistance. Recruitment usually occurs in zone 1 of the lung (apices), where the capillary pressures are the lowest.</p>
        <p>Capillary distension is the second mechanism and involves widening the capillaries to accommodate increased blood flow. The Ovular vessels become more circular, the predominant mechanism for maintaining low PVR at higher pulmonary arterial pressures.<xref ref-type="bibr" rid="article-28057.r1">[1]</xref></p>
        <p>
<bold>Lung Volumes</bold>
</p>
        <p>Alveolar pressures and volumes influence pulmonary vascular resistance. The effect of lung volume depends on the type of&#x000a0;vessel. Extra-alveolar vessels run through the lung parenchyma. These vessels have smooth muscle and elastic tissue, which reduces vessel circumference by counteracting distension. As the lung expands, the diameter of these vessels increases via radial traction of the vessel walls. Therefore, vascular resistance is low at large lung volumes. During low lung volumes, there is&#x000a0;high resistance due to the unopposed action of vessel elasticity.</p>
        <p>Critical opening pressure represents the air pressure facilitating&#x000a0;blood flow through extra-alveolar capillaries. This concept applies when modeling vascular resistance in a collapsed lung with low volume.</p>
        <p>Alveolar capillaries include capillaries and vessels in the corner of the alveolar walls. Their transmural pressure determines the amount of lung distension.</p>
        <p>Alveolar pressure is highest in zone 1 (near the apices) and lowest in zone 3 (near the bases). During inspiration, alveolar pressure rises,&#x000a0;compressing the surrounding alveolar capillaries. With increased right heart return&#x000a0;on inspiration, stretching and thinning of the alveolar walls reduces capillary caliber and increases PVR. PVR is highest at total lung capacity (TLC), high at residual volume (RV), and lowest at functional residual capacity (FRC) (see <bold>Image.&#x000a0;</bold>Standard Lung Volumes and Capacities).<xref ref-type="bibr" rid="article-28057.r5">[5]</xref></p>
        <p>
<bold>Gravity</bold>
</p>
        <p>Three zones of the lung are typically identified (see <bold>Image.&#x000a0;</bold>Normal PA Chest X-Ray Delineated by Lung Zones). PVR is greatest at zone 1 since the elevated alveolar pressure increases the inward transmural pressure on the alveolar-capillary membrane. The capillary becomes collapsible, and the resistance increases. PVR is lowest at zone 3, where the arterial pressure is higher than the alveolar pressure, causing an increased outward transmural pressure and vessel caliber.<xref ref-type="bibr" rid="article-28057.r6">[6]</xref></p>
        <p>
<bold>Alveolar Hypoxia</bold>
</p>
        <p>Hypoxia within the alveoli induces vasoconstriction within the lung vasculature. This homeostatic mechanism allows the lungs to shunt blood to more oxygenated lung segments,&#x000a0;increasing the ventilation/perfusion (V/Q) ratio and improving oxygen delivery throughout the body.</p>
        <p>This mechanism&#x000a0;is&#x000a0;important when the lungs are exposed to disruptive processes, such as consolidation (eg, pneumonia) or blockage within the vasculature (eg, pulmonary emboli),&#x000a0;leading to physiological&#x000a0;compensation.&#x000a0;The theory is that this response begins at the molecular level when a mitochondrial sensor utilizes redox coupling reactions to alter the elasticity of pulmonary artery smooth muscle cells (PASMC).</p>
        <p>The redox reactions lead to the depolarization of PASMC via activation of voltage-gated calcium channels and inhibition of potassium channels,&#x000a0;causing decreased elasticity within the arterioles of hypoxic lung segments. If hypoxia is sustained, alternative pathways&#x000a0;are activated (eg, rho kinase), and the&#x000a0;chemokine release&#x000a0;(eg, hypoxia-inducible factor (HIF)-1 alpha) leads to&#x000a0;vasoconstrictive effects and vasculature remodeling.<xref ref-type="bibr" rid="article-28057.r7">[7]</xref></p>
        <p>
<bold>Smooth Muscle Tonicity</bold>
</p>
        <p>Generally, the pulmonary circulation has a low vascular tone due to pulmonary vessels having proportionately less smooth muscle than vessels of similar diameter in other organs. Compared to systemic vessels, the smooth muscle tissue in pulmonary vessels is distributed less evenly in the tunica intima. The pulmonary veins are also more compliant than systemic arteries due to the lack of tissue around small vessels, reduced elastin and collagen fibers, and&#x000a0;reduced smooth muscle content.&#x000a0;This phenomenon is demonstrated by the pressure gradient between the right and left ventricles.<xref ref-type="bibr" rid="article-28057.r2">[2]</xref><xref ref-type="bibr" rid="article-28057.r8">[8]</xref></p>
        <p>Pulmonary arteries are both elastic and muscular. These arteries contain smooth muscle within the tunica media surrounded by internal and external elastic laminae. These include the pulmonary artery trunk, main branches, and extra-alveolar vessels. Larger, peri-bronchial arteries are more muscular (&#x0003e;2mm). Peri-bronchial arteries lie within the lung lobules. These extra-alveolar arteries control PVR through neural, humoral, or gaseous mediators. As the vessels&#x000a0;are smaller, smooth muscle content decreases. The smooth muscle takes on a spiral shape and&#x000a0;forms the pulmonary arterioles that supply alveoli and alveolar ducts. Smooth muscle exceeding 5% of the external diameter is considered pathological.</p>
        <p>Pulmonary arteries have&#x000a0;more&#x000a0;smooth muscle than veins and represent vasoactive mediators' constriction sites. Capillaries are devoid of vasomotor control. Factors that cause increased tone and increased PVR include serotonin, epinephrine, norepinephrine, histamine, ATP, adenosine, neurokinin A, endothelin, angiotensin, thromboxane A/prostaglandins/leukotrienes (LTB). Most of these factors act through a G-protein coupled pathway, which activates myosin contraction. Neuronally, pulmonary constriction is under the mediation of the sympathetic nervous system&#x000a0;by stimulation of a1 adrenergic receptors.<xref ref-type="bibr" rid="article-28057.r9">[9]</xref></p>
        <p>Factors that decrease smooth muscle tonicity and PVR include acetylcholine and isoproterenol, prostacyclin (PGI), bradykinin, vasopressin, ANP, substance P, VIP, and histamine (during adrenaline response). Most of the factors act through activation of cyclic adenosine 3&#x02019;,5&#x02019; monophosphate (cAMP). cAMP de-phosphorylates myosin and reduces calcium levels, causing relaxation of smooth muscle. Pulmonary endothelial cells cause relaxation by producing nitric oxide (NO).</p>
        <p>NO diffuses through smooth muscle cells and activates cyclic guanosine 3&#x02019;, 5&#x02019; monophosphate (cGMP), which causes smooth muscle relaxation&#x000a0;by the de-phosphorylation of myosin. Additionally,&#x000a0;stimuli from the parasympathetic nervous system via the vagus nerve on M muscarinic receptors in the vasculature cause NO-dependent vasodilation.<xref ref-type="bibr" rid="article-28057.r9">[9]</xref></p>
      </sec>
      <sec id="article-28057.s3" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Disease processes that cause chronic hypoxia increase pulmonary vascular resistance through hypoxic pulmonary vasoconstriction that remodels the vessels of the pulmonary circulation over time. These include pulmonary edema, pulmonary emboli, and cardiovascular disease.</p>
        <p>Pulmonary edema causes alveoli to shrink due to increased surface tension, causing hypoxemia and shunting of blood to areas of&#x000a0;higher ventilation. Hypoxia induces vasoconstriction, leading to pulmonary hypertension and increased vascular resistance. Peri-bronchial cuffing increases the resistance of extra-alveolar vessels, while alveolar edema compresses and distorts capillaries.</p>
        <p>Recruitment and distension of pulmonary capillaries provide a large reserve in the pulmonary circulation. Half of the pulmonary circulation can become obstructed before a detectable rise in pulmonary pressure occurs. While the mechanism of increased PVR secondary to pulmonary embolism is still under research, current understanding suggests that it is caused by serotonin release from platelets.</p>
        <p>Cardiovascular disease may also lead to increased pulmonary vascular resistance. Left heart valvular disease, such as mitral stenosis or regurgitation, leads to elevated pressures in the left atrium and, ultimately, the pulmonary veins. Increases in pulmonary capillary pressures over a long period lead to smooth muscle hypertrophy and fibrosis of pulmonary vasculature. These changes, in turn,&#x000a0;cause pulmonary arterial hypertension and eventually cor pulmonale.</p>
      </sec>
      <sec id="article-28057.s4" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Increased pulmonary vascular resistance is the leading cause of pulmonary hypertension.<xref ref-type="bibr" rid="article-28057.r10">[10]</xref>&#x000a0;Furthermore, increased PVR can lead to pulmonary hypertension, leading to increased PVR due to chronic vasoconstriction, vascular remodeling, endothelial thickening, arteriolar smooth muscle hypertrophy, and increased thromboxane and endothelin-1 production.</p>
        <p>Pulmonary hypertension is a mean pressure greater than 25 mm Hg and a PVR greater than 3 mmHg&#x000b7;min/l. This measurement is obtained through a right heart catheterization (eg, Swan-Ganz catheters).<xref ref-type="bibr" rid="article-28057.r11">[11]</xref>&#x000a0;</p>
        <p>Increased PVR may occur secondary to processes that cause hypoxic pulmonary vasoconstriction or neurally mediated vasoconstriction (catecholamine release). These processes include chronic obstructive pulmonary disease, emphysema, pulmonary fibrosis, cystic fibrosis, sleep apnea, lupus, scleroderma, rheumatoid arthritis, and HIV. Vascular obstruction secondary to venous thromboembolism, air embolus, amniotic fluid, and schistosomiasis also causes an increase in pulmonary vascular resistance, leading to pulmonary hypertension. Obliterative processes such as pulmonary vasculitides destroy capillary beds, ultimately increasing PVR in certain areas.<xref ref-type="bibr" rid="article-28057.r7">[7]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-28057.s5">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28057&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28057">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28057/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28057">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-28057.s6">
        <fig id="article-28057.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Pulmonary Vascular Resistance Derived from Ohm's Law. Pulmonary vascular resistance derived from Ohm's law, factoring input and output blood pressure in relation to blood flow. Contributed by Vivek Ashok</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="PVRFigure1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-28057.s7">
        <fig id="article-28057.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Poiseuille's Law Modeling Pulmonary Vascular Resistance.&#x000a0;Resistance is also derived from Poiseuille's Law that can measure blood vessel parameters. Contributed by Vivek Ashok</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="PVRFigure2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-28057.s8">
        <fig id="article-28057.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Standard Lung Volumes and Capacities.&#x000a0;Standard lung volumes and capacities that may be affected by pulmonary disease. Contributed by Lutfi MF. The physiological basis and clinical significance of lung volume measurements. Multidisciplinary Respiratory Medicine. 2017;12:3. (CC by 4.0; Creative Commons Attribution 4.0 International License)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Lung__Volumes" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-28057.s9">
        <fig id="article-28057.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Normal PA Chest X-Ray Delineated by Lung Zones.&#x000a0;Normal Chest x-ray showing upper zone: from the apex to 2nd costal cartilage, middle zone: between 2nd and 4th costal cartilage, and lower zone: between 4th and 6th costal cartilage. iEM for Medical Students and Interns. CC BY-NC-SA 2.0 DEED https://creativecommons.org/licenses/by-nc-sa/2.0/</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="lung__zones" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-28057.s10">
        <title>References</title>
        <ref id="article-28057.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lai</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Potoka</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Champion</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Mora</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Gladwin</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary arterial hypertension: the clinical syndrome.</article-title>
            <source>Circ Res</source>
            <year>2014</year>
            <month>Jun</month>
            <day>20</day>
            <volume>115</volume>
            <issue>1</issue>
            <fpage>115</fpage>
            <page-range>115-30</page-range>
            <pub-id pub-id-type="pmid">24951762</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28057.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghio</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schirinzi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pica</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary arterial compliance: How and why should we measure it?</article-title>
            <source>Glob Cardiol Sci Pract</source>
            <year>2015</year>
            <volume>2015</volume>
            <issue>4</issue>
            <fpage>58</fpage>
            <pub-id pub-id-type="pmid">26779530</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28057.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poullis</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Central and peripheral pulmonary vascular resistance: Implications for who should undergo pulmonary thromboendarterectomy.</article-title>
            <source>Med Hypotheses</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>85</volume>
            <issue>2</issue>
            <fpage>113</fpage>
            <page-range>113-6</page-range>
            <pub-id pub-id-type="pmid">25997984</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28057.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thenappan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ormiston</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Archer</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary arterial hypertension: pathogenesis and clinical management.</article-title>
            <source>BMJ</source>
            <year>2018</year>
            <month>Mar</month>
            <day>14</day>
            <volume>360</volume>
            <fpage>j5492</fpage>
            <pub-id pub-id-type="pmid">29540357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28057.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suresh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shimoda</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Lung Circulation.</article-title>
            <source>Compr Physiol</source>
            <year>2016</year>
            <month>Mar</month>
            <day>15</day>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>897</fpage>
            <page-range>897-943</page-range>
            <pub-id pub-id-type="pmid">27065170</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28057.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levitzky</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Teaching the effects of gravity and intravascular and alveolar pressures on the distribution of pulmonary blood flow using a classic paper by West et al.</article-title>
            <source>Adv Physiol Educ</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <page-range>5-8</page-range>
            <pub-id pub-id-type="pmid">16481601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28057.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dunham-Snary</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sykes</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Thakrar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Parlow</surname>
                <given-names>LRG</given-names>
              </name>
              <name>
                <surname>Mewburn</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Parlow</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Archer</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Hypoxic Pulmonary Vasoconstriction: From Molecular Mechanisms to Medicine.</article-title>
            <source>Chest</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>151</volume>
            <issue>1</issue>
            <fpage>181</fpage>
            <page-range>181-192</page-range>
            <pub-id pub-id-type="pmid">27645688</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28057.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wagenseil</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Mecham</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Vascular extracellular matrix and arterial mechanics.</article-title>
            <source>Physiol Rev</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>89</volume>
            <issue>3</issue>
            <fpage>957</fpage>
            <page-range>957-89</page-range>
            <pub-id pub-id-type="pmid">19584318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28057.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Raj</surname>
                <given-names>JU</given-names>
              </name>
            </person-group>
            <article-title>Endothelial and Smooth Muscle Cell Interactions in the Pathobiology of Pulmonary Hypertension.</article-title>
            <source>Am J Respir Cell Mol Biol</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>54</volume>
            <issue>4</issue>
            <fpage>451</fpage>
            <page-range>451-60</page-range>
            <pub-id pub-id-type="pmid">26744837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28057.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dunlap</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Weyer</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary Hypertension: Diagnosis and Treatment.</article-title>
            <source>Am Fam Physician</source>
            <year>2016</year>
            <month>Sep</month>
            <day>15</day>
            <volume>94</volume>
            <issue>6</issue>
            <fpage>463</fpage>
            <page-range>463-9</page-range>
            <pub-id pub-id-type="pmid">27637122</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28057.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kwan</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Shavelle</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Laughrun</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary vascular resistance index: Getting the units right and why it matters.</article-title>
            <source>Clin Cardiol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>42</volume>
            <issue>3</issue>
            <fpage>334</fpage>
            <page-range>334-338</page-range>
            <pub-id pub-id-type="pmid">30614019</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
